Literature DB >> 36137654

Surgical or Endovascular Treatment of MCA Aneurysms: An Agreement Study.

W Boisseau1, T E Darsaut2, R Fahed3, J M Findlay2, R Bourcier4, G Charbonnier5, S Smajda6, J Ognard7, D Roy1, F Gariel8, A P Carlson9, E Shotar10, G Ciccio11, G Marnat8, P B Sporns12,13, T Gaberel14, V Jecko15, A Weill1, A Biondi5, G Boulouis16, A L Bras17, S Aldea18, T Passeri19, S Boissonneau20,21, N Bougaci22, J C Gentric7, J D B Diestro23, A T Omar24, H M Al-Jehani25, G El Hage26, D Volders27, Z Kaderali28, I Tsogkas12, E Magro29, Q Holay30, J Zehr31, D Iancu1, J Raymond32.   

Abstract

BACKGROUND AND
PURPOSE: MCA aneurysms are still commonly clipped surgically despite the recent development of a number of endovascular tools and techniques. We measured clinical uncertainty by studying the reliability of decisions made for patients with middle cerebral artery (MCA) aneurysms.
MATERIALS AND METHODS: A portfolio of 60 MCA aneurysms was presented to surgical and endovascular specialists who were asked whether they considered surgery or endovascular treatment to be an option, whether they would consider recruitment of the patient in a randomized trial, and whether they would provide their final management recommendation. Agreement was studied using κ statistics. Intrarater reliability was assessed with the same, permuted portfolio of cases of MCA aneurysm sent to the same specialists 1 month later.
RESULTS: Surgical management was the preferred option for neurosurgeons (n = 844/1320; [64%] responses/22 raters), while endovascular treatment was more commonly chosen by interventional neuroradiologists (1149/1500 [76.6%] responses/25 raters). Interrater agreement was only "slight" for all cases and all judges (κ = 0.094; 95% CI, 0.068-0.130). Agreement was no better within specialties or with more experience. On delayed requestioning, 11 of 35 raters (31%) disagreed with themselves on at least 20% of cases. Surgical management and endovascular treatment were always judged to be a treatment option, for all patients. Trial participation was offered to patients 65% of the time.
CONCLUSIONS: Individual clinicians did not agree regarding the best management of patients with MCA aneurysms. A randomized trial comparing endovascular with surgical management of patients with MCA aneurysms is in order.
© 2022 by American Journal of Neuroradiology.

Entities:  

Year:  2022        PMID: 36137654      PMCID: PMC9575541          DOI: 10.3174/ajnr.A7648

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   4.966


  30 in total

1.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

2.  Stenting for intracranial aneurysms: how to paint oneself into the proverbial corner.

Authors:  J Raymond; T E Darsaut
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-08       Impact factor: 3.825

3.  Editorial: Clip or coil? Six years of follow-up in BRAT.

Authors:  R Loch Macdonald
Journal:  J Neurosurg       Date:  2015-06-26       Impact factor: 5.115

4.  International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.

Authors:  Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

5.  The RISE trial: A Randomized Trial on Intra-Saccular Endobridge devices.

Authors:  Jean Raymond; Anne-Christine Januel; Daniela Iancu; Daniel Roy; Alain Weill; Andrew Carlson; Tim E Darsaut
Journal:  Interv Neuroradiol       Date:  2019-11-05       Impact factor: 1.610

6.  The Barrow Ruptured Aneurysm Trial.

Authors:  Cameron G McDougall; Robert F Spetzler; Joseph M Zabramski; Shahram Partovi; Nancy K Hills; Peter Nakaji; Felipe C Albuquerque
Journal:  J Neurosurg       Date:  2011-11-04       Impact factor: 5.115

7.  The design of the Canadian UnRuptured Endovascular versus Surgery (CURES) trial.

Authors:  Tim E Darsaut; J Max Findlay; Jean Raymond
Journal:  Can J Neurol Sci       Date:  2011-03       Impact factor: 2.104

8.  Middle Cerebral Artery Aneurysm Trial (MCAAT): A Randomized Care Trial Comparing Surgical and Endovascular Management of MCA Aneurysm Patients.

Authors:  Tim E Darsaut; Michael B Keough; William Boisseau; J Max Findlay; Michel W Bojanowski; Chiraz Chaalala; Daniela Iancu; Alain Weill; Daniel Roy; Laurent Estrade; Jean-Paul Lejeune; Anne-Christine Januel; Andrew P Carlson; Eric Sauvageau; Hosam Al-Jehani; Kirill Orlov; Sorin Aldea; Michel Piotin; Thomas Gaberel; Guylaine Gevry; Jean Raymond
Journal:  World Neurosurg       Date:  2021-12-28       Impact factor: 2.210

9.  Measuring clinical uncertainty and equipoise by applying the agreement study methodology to patient management decisions.

Authors:  Robert Fahed; Tim E Darsaut; Behzad Farzin; Miguel Chagnon; Jean Raymond
Journal:  BMC Med Res Methodol       Date:  2020-08-25       Impact factor: 4.615

10.  Retreatments must be included in the evaluation of device performance.

Authors:  René Chapot; Pascal J Mosimann; Tim E Darsaut; Jean Raymond
Journal:  J Neurointerv Surg       Date:  2020-09-14       Impact factor: 5.836

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.